Imagine a world without cancer.
At the 2016 American Association for Cancer Research annual meeting today, scientists presented their results of a follow-up study tracking the survival of metastatic melanoma… Read More »One-third of patients with metastatic melanoma treated with immunotherapy drug nivolumab survive five years
***Note: This is the final post of a four-part feature story, written by Elizabeth Huebeck. Read part one on Kristin's story, part two on cancer as… Read More »Pay close attention to your overall health
***Note: This is the third of a four-part feature story, written by Elizabeth Huebeck. Read part one on Kristin's story and part two on cancer as a… Read More »Strategies for staying the course
***Note: This is the second of a four-part feature story, written by Elizabeth Huebeck. Read part one on Kristin's story. Statistics show that the five-year survival… Read More »The model patient for cancer as chronic disease
"I, along with the other cancer patients and survivors, have waited more than 20 years to see this day arrive," says Johns Hopkins champion Sidney… Read More »Possibilities – Bloomberg~Kimmel Institute for Cancer Immunotherapy
***This is the first of a four-part feature story, written by Elizabeth Huebeck. Read part two on cancer as a chronic disease, part three on Kristin's strategies… Read More »Kristin Franceschi hasn’t let Stage IV colon cancer slow her dance steps
Vice President Joe Biden spoke to researchers, medical students, government leaders and others during the dedication of the new Bloomberg~Kimmel Institute for Cancer Immunotherapy. It… Read More »Vice President Biden Speaks at Launch of Bloomberg~Kimmel Institute for Cancer Immunotherapy
***This blog is the third in a three-part series on bladder cancer. Read parts one and two. The Johns Hopkins Greenberg Bladder Cancer Institute held… Read More »Symposium Spotlight on Bladder Cancer
***This blog is the second in a three-part series on bladder cancer. Read part one. Trinity Bivalacqua, M.D., Ph.D., director of urologic oncology in the… Read More »Bivalacqua Directs Bladder Cancer Advocacy Network Meeting Panel
***This blog is the first in a three-part series on bladder cancer. For too long, bladder cancer has been called the invisible cancer. But a… Read More »Bladder Cancer: No Longer Invisible